Terremoto Biosciences Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 46

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $175M

  • Investors
  • 5

Terremoto Biosciences General Information

Description

Developer of Drug delivery and discovery platform designed for small-molecule medicines. The company's platform features the ability to deliver medicines with optimized clinical profiles, superior therapeutic benefits, and cures for devastating diseases, enabling healthcare sector businesses to improve current medicines and create new therapies with optimized clinical profiles.

Contact Information

Website
www.terremotobio.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1700 Owens Street
  • Suite 540
  • San Francisco, CA 94158
  • United States
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Vertical(s)
HealthTech
Corporate Office
  • 1700 Owens Street
  • Suite 540
  • San Francisco, CA 94158
  • United States

Terremoto Biosciences Timeline

202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Terremoto Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 02-Nov-2023 $175M Completed Startup
1. Early Stage VC (Series A) 25-May-2022 Completed Startup
To view Terremoto Biosciences’s complete valuation and funding history, request access »

Terremoto Biosciences Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
To view Terremoto Biosciences’s complete cap table history, request access »

Terremoto Biosciences Executive Team (7)

Name Title Board Seat
Russell Lipford Ph.D Chief Scientific Officer
Vivian Ho Senior Director of Finance and Accounting
Wayne Spevak Ph.D Senior Vice President, Chemistry, Biology and Pharmacology
Kevin Koch Ph.D Scientific Advisor
Matthew Jacobson Ph.D Co-Founder & Scientific Advisors
You’re viewing 5 of 7 executive team members. Get the full list »

Terremoto Biosciences Board Members (5)

Name Representing Role Since
Charles Baum Ph.D Self Chief Executive Officer
Jack Taunton Ph.D Self Co-Founder, Board Member & Scientific Advisor
Jeffrey Tong Ph.D Third Rock Ventures Board Member
Peter Thompson MD Self Co-Founder & Chairman
Reid Huber Ph.D Third Rock Ventures Board Member & Scientific Advisor
To view Terremoto Biosciences’s complete board members history, request access »

Terremoto Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Terremoto Biosciences Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
Cormorant Capital Real Estate Minority
EcoR1 Capital Venture Capital Minority
Novo Holdings Asset Manager Minority
OrbiMed Growth/Expansion Minority
Third Rock Ventures Venture Capital Minority
To view Terremoto Biosciences’s complete investors history, request access »

Ready to get started?

Request a free trial

Terremoto Biosciences FAQs

  • When was Terremoto Biosciences founded?

    Terremoto Biosciences was founded in 2021.

  • Who is the founder of Terremoto Biosciences?

    Matthew Jacobson Ph.D, Peter Thompson MD, and Jack Taunton Ph.D are the founders of Terremoto Biosciences.

  • Where is Terremoto Biosciences headquartered?

    Terremoto Biosciences is headquartered in San Francisco, CA.

  • What is the size of Terremoto Biosciences?

    Terremoto Biosciences has 46 total employees.

  • What industry is Terremoto Biosciences in?

    Terremoto Biosciences’s primary industry is Drug Delivery.

  • Is Terremoto Biosciences a private or public company?

    Terremoto Biosciences is a Private company.

  • What is Terremoto Biosciences’s current revenue?

    The current revenue for Terremoto Biosciences is .

  • How much funding has Terremoto Biosciences raised over time?

    Terremoto Biosciences has raised $250M.

  • Who are Terremoto Biosciences’s investors?

    Cormorant Capital, EcoR1 Capital, Novo Holdings, OrbiMed, and Third Rock Ventures have invested in Terremoto Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »